Bosseray, A <br/><br/>
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].  [electronic resource] 

 -  Pathologie-biologie  Oct 1992 
 - 797-804 p.  digital 
<br/><br/> Publication Type: Clinical Trial; English Abstract; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0369-8114 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amikacin--therapeutic use<br/>Bacterial Infections--drug therapy<br/>Ceftazidime--therapeutic use<br/>Cilastatin--therapeutic use<br/>Drug Therapy, Combination--therapeutic use<br/>Female<br/>Humans<br/>Imipenem--therapeutic use<br/>Male<br/>Middle Aged<br/>Neutropenia--drug therapy<br/>Prospective Studies<br/>Ticarcillin--therapeutic use<br/>Vancomycin--therapeutic use